Entry Detail



General Information

Database ID:exR0359581
RNA Name:ALDH3A2
RNA Type:mRNA
Chromosome:chr17
Starnd:+
Coordinate:
Start Site(bp):19648136End Site(bp):19685760
External Links:ENSG00000072210



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
BLM
chr15
90717346
90816166
+
C4orf3
chr4
119296419
119304445
-
KMT2D
chr12
49018975
49059774
-
EIF5A
chr17
7306999
7312463
+
PRSS16
chr6
27247701
27256624
+
NPM1
chr5
171387116
171411137
+
ERGIC3
chr20
35542021
35557634
+
BST2
chr19
17402939
17405630
-
IQGAP1
chr15
90388242
90502239
+
HMGCR
chr5
75336329
75362101
+
MTRNR2L3
chr20
57358447
57359498
-
PEA15
chr1
160205337
160215376
+
BOD1
chr5
173607145
173616659
-
TUBA1A
chr12
49184795
49189080
-
SPCS1
chr3
52704955
52711148
+
DGLUCY
chr14
91060333
91225632
+
GID8
chr20
62938147
62948475
+
ENSA
chr1
150600851
150629612
-
RSL24D1
chr15
55180806
55197049
-
ARPC2
chr2
218217141
218254356
+
ZNF431
chr19
21142024
21196053
+
MFGE8
chr15
88898683
88913381
-
MIF
chr22
23894383
23895227
+
MPC2
chr1
167916675
167937072
-
TNFRSF14
chr1
2555639
2565382
+
SOX8
chr16
981770
986979
+
PDZD8
chr10
117277274
117375440
-
BCR
chr22
23179704
23318037
+
AK2
chr1
33007940
33080996
-
AMACR
chr5
33986165
34008104
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-19b-3p
chr13
91351245
91351267
+
hsa-miR-27a-3p
chr19
13836447
13836467
-
hsa-miR-27b-3p
chr9
95085505
95085525
+
hsa-miR-301a-3p
chr17
59151149
59151171
-
hsa-miR-431-5p
chr14
100881026
100881046
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
SCARNA9
chr11
93721513
93721865
+
SNHG16
chr17
76557764
76565348
+
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.